Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SVB Leerink Maintains Outperform on Innate Pharma, Lowers Price Target to $9

SVB Leerink Maintains Outperform on Innate Pharma, Lowers Price Target to $9

SVB Leerink analyst Daina Graybosch maintains Innate Pharma (NASDAQ:IPHA) with a Outperform and lowers the price target from $10 to $9.

November 15, 2022

1 minute read

SVB Leerink analyst Daina Graybosch maintains Innate Pharma (NASDAQ:IPHA) with a Outperform and lowers the price target from $10 to $9.

Why This Super Micro Computer Analyst Is Bullish: ‘Revenues Could Grow Even Faster’

February 15, 1:46 PM

Super Micro Computer Inc (NASDAQ: SMCI) has been among the main beneficiaries of the artificial intelligence (AI) market explosion.

November 28, 10:41 AM

Affirm Holdings Inc (NASDAQ: AFRM) shares are volatile Tuesday after closing up 12% on Monday.

December 12, 8:01 PM

https://twitter.com/SDNYnews/status/1602451395910803457

August 18, 3:35 AM

With US stock futures trading slightly lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: